Frazier Life Sciences Management, L.P. - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Frazier Life Sciences Management, L.P. ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$8,730,177
-2.1%
3,746,8570.0%0.58%
+8.8%
Q2 2023$8,917,520
+29.3%
3,746,8570.0%0.53%
+6.8%
Q1 2023$6,894,217
-3.2%
3,746,8570.0%0.50%
+12.6%
Q4 2022$7,119,028
-11.2%
3,746,8570.0%0.44%
-28.2%
Q3 2022$8,018,000
-24.4%
3,746,8570.0%0.62%
-38.4%
Q2 2022$10,604,000
-32.1%
3,746,8570.0%1.00%
-24.8%
Q1 2022$15,624,0003,746,8571.33%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,300,000$17,160,0002.55%
Alphabet Inc. 699,352$9,231,0000.56%
DAFNA Capital Management LLC 100,000$1,320,0000.45%
JUPITER ASSET MANAGEMENT LTD 705,356$9,311,0000.29%
Artal Group S.A. 500,000$6,600,0000.26%
Cormorant Asset Management, LP 479,988$6,336,0000.25%
MPM BioImpact LLC 39,740$525,0000.19%
Granahan Investment Management 305,158$4,028,0000.18%
Burrage Capital Management LLC 13,113$173,0000.12%
Vident Investment Advisory, LLC 118,866$1,569,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders